Boehringer Ingelheim, NIPER Raebareli Sign MoU on Pharmaceutical Research Collaboration

Boehringer Ingelheim India Private Limited has signed a Memorandum of Understanding (MoU) with the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, including its Centre of Excellence for Novel Drug Delivery Systems (CoE-NDDS), to advance collaboration in pharmaceutical education and research. The MoU was signed at the Department of Pharmaceuticals in the presence of Shri Manoj Joshi, IAS, Secretary, Department of Pharmaceuticals.

The MoU establishes a framework to strengthen academic and research collaboration in areas such as pharmaceutical technologies, novel drug delivery systems, joint research initiatives, academic exchange, and capability-building programmes.

As part of this MoU, Boehringer Ingelheim will support NIPER Raebareli by enabling access to opnMe®, which is Boehringer Ingelheim's open science portal, designed to connect with researchers and institutions to accelerate scientific progress and enable innovation in healthcare. The partnership will also explore opportunities for symposia, conferences, short-term courses, and scholar engagement, helping strengthen learning, research, and scientific exchange.

The managing director stated, "India is entering an important phase in its pharmaceutical journey, moving from scale-led growth to innovation-led impact. At Boehringer Ingelheim, we believe progress in healthcare is accelerated when industry, academia, and public institutions come together. This MoU with NIPER Raebareli reflects our commitment to strengthening scientific capability and supporting collaborations that can contribute to better health outcomes for patients and communities."

The director stated, "This MoU supports our vision of advancing pharmaceutical education and research while enabling opportunities for students and researchers to contribute to areas of emerging importance such as novel drug delivery systems and community health solutions. We look forward to working with Boehringer Ingelheim to create meaningful opportunities for students and researchers and to contribute to India's innovation ecosystem."

Also present at the MoU signing ceremony were Shri Awadhesh Kumar Choudhary, Senior Economic Advisor, Department of Pharmaceuticals, and Ms. Anugraha P, Director, Department of Pharmaceuticals.

The collaboration aligns with India's broader efforts to transition its pharmaceutical sector from a volume-driven and generic-led model to a more innovation-focused and research-driven ecosystem. Strengthening industry-academia linkages is seen as a key component of this shift, supporting the country's long-term healthcare and innovation goals under the Viksit Bharat 2047 vision.

By strengthening the bridge between academic research and industry expertise, this partnership aims to contribute to the development of future-ready scientific talent and research pathways that can support more effective, accessible, and patient-centric healthcare solutions over time.